NovoLog PenFill and Ocrelizumab Intravenous
Determining the interaction of NovoLog PenFill and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Ocrevus
- NovoLog PenFill-Octagam
- NovoLog PenFill-Octagam Gammagard S/D
- NovoLog PenFill-Octocaine
- NovoLog PenFill-Octocaine 100
- NovoLog PenFill-OctreoScan
- Ocrelizumab Intravenous-Novoseven
- Ocrelizumab Intravenous-NovoSeven RT
- Ocrelizumab Intravenous-NovoSeven RT with MixPro injection
- Ocrelizumab Intravenous-Novothyrox
- Ocrelizumab Intravenous-Noxafil
- Ocrelizumab Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)